$116.50+1.55 (+1.35%)
T.
T. Rowe Price Group, Inc. in the Financial Services sector is trading at $116.50 with a market capitalization of $23.3B. Wall Street consensus targets $110.00 (12 analysts), implying a -5.6% move over the next 12 months. The stock is currently near its 52-week high of $121.17, remaining 16.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.86B↓ | $1.93B↑ | $1.89B↑ | $1.72B↓ | $1.76B |
| Gross Profit | $1.02B↑ | $995.30M↓ | $1.00B↑ | $828.30M↓ | $922.00M |
| Operating Income | $708.50M↑ | $644.40M↓ | $698.50M↑ | $509.50M↓ | $625.00M |
| Net Income | $498.20M↑ | $445.30M↓ | $646.10M↑ | $505.20M↑ | $490.50M |
T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mu...
T. Rowe Price (TROW) concluded the recent trading session at $116.5, signifying a +1.35% move from its prior day's close.
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Financial experts usually advise against dumping all stocks, but there are three instances when you can safely say goodbye to market risk.
Some of the quietest stocks on Wall Street have been raising dividends for decades without missing a beat, and four financial sector names in particular have built a case for reliability that most headline-grabbing growth stocks cannot match.